I would like to attend the hearing, but, unlike an annual meeting, hearings can be postponed as was the case with Medizone. I did send a letter, via email, to Mr. Schwartzer offering a little history of the last decade of the company and how shareholders were deprived of representation between 2009 and 2016. If the recent press releases were true, our new management was engaged with the FDA, was working on a global social media awareness program with Innovasource, and was in the middle of a fund raising campaign. Would you or I, as a prior officer of the company holding several million shares, cut-off the only momentum the company had seen in its lifetime? Both of these bankruptcies should be thrown out, and the old and new management should be at the negotiating table working out a payment plan while prospects for the business forge ahead.